Streetbeat News

Products Services

SEER

Seer, Inc. (NASDAQ:SEER) announced a study published in Nature Communications, led by Weill Cornell Medicine, showcasing the capabilities of Seer's Proteograph workflow in proteogenomics. The study, which utilized Seer's Proteograph Assay, identified over 18,000 peptides from around 3,000 proteins in blood samples, revealing 184 protein-altering variants in 137 genes. This breakthrough enables unprecedented mapping of genetic markers for drug and biomarker discovery, overcoming limitations of traditional affinity-based methods. Seer's Proteograph XT Assay Kit further enhances this by doubling throughput and maintaining high-resolution insights, supporting large-scale proteogenomic studies and precision medicine.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:10 pm

SRTS

Sensus Healthcare has announced a collaboration with CureRays, aiming to provide oversight and supervision for Sensus' dermatology customers. Additionally, CureRays will research new indications for Sensus' Superficial Radiotherapy (SRT), potentially expanding its market to include inflammatory diseases.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:09 pm

AMRK

A-Mark Precious Metals, Inc. (AMRK) plans to acquire LPM Group Limited from AMS Holding, LLC for $41.5M, marking its expansion into Asia. The deal includes a mix of cash and AMRK stock, with additional performance-based payments. LPM, a major precious metals dealer in Asia, will benefit from A-Mark's resources and e-commerce expertise. Additionally, A-Mark affiliate Pinehurst Coin Exchange will acquire assets from ModernCoinMart for $5.5M, and a joint venture will invest in AMS Holdings. The transactions aim to enhance A-Mark's global presence and product offerings.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:08 pm

RLYB

Rallybio announced a strategic portfolio prioritization focusing on Phase 2-ready programs RLYB212 and RLYB116, alongside a 45% workforce reduction aimed at extending its cash runway into mid-2026.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:06 pm

MGA

Magna (MGA) has been awarded a contract by a North America-based OEM to supply a specialized primary rear eDrive system for a high-end niche vehicle platform. This system, a variant of Magna's 800V eDS Duo, integrates two e-motors, two inverters, and two gearboxes, delivering 726 kW of power and 8,000 Nm of torque. The contract highlights Magna's expertise in electric powertrain system engineering and integration. The system will be manufactured in Magna's facility in Ramos, Mexico, with production starting in the next few years.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:06 pm

BSX

Boston Scientific Corporation (NYSE:BSX) received FDA approval for an expanded indication of its WaveWriter SCS Systems to treat chronic low back and leg pain in individuals without prior back surgery, known as non-surgical back pain (NSBP).

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:05 pm

MA

NovoPayment has partnered with Mastercard to expand its operations in Mexico through the Mastercard Network Enablement Partner program. This certification allows NovoPayment to process Mastercard transactions in Mexico, enhancing its multi-rail payments strategy and offering greater choice and flexibility to its clients. NovoPayment aims to leverage this partnership to expedite product innovation, reduce time to market, and improve operational efficiency.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:05 pm

GTEC

Greenland Technologies Holding Corporation (NASDAQ:GTEC), a developer and manufacturer of electric industrial vehicles and drivetrain systems, has expanded its HEVI Authorized Service Provider (ASP) network by adding Correlli Incorporated. This expansion is aimed at supporting the growing demand for Greenland's HEVI electric industrial vehicle product line.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:04 pm

INVZ

Innoviz Technologies has received the IATF 16949:2016 certification for its design and assembly of Lidar, Perception SW, and Lidar solutions, reinforcing its status as a reliable Tier-1 supplier.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:04 pm

AWH

Aspira Women's Health has entered into a 5-year distribution agreement with Hi-Precision Laboratories in the Philippines for its OvaSuite product line. This partnership aims to enhance the availability and accessibility of Aspira's ovarian cancer diagnostic tests in the region, potentially increasing the company's market presence and revenue streams in Southeast Asia.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:04 pm